The future of medical devices has much potential, but they also have risks related to cybersecurity. In 2024, we saw the first full year of the Food and Drug Administration’s (FDA) new guidance ...
At MD&M West, PIA will give attendees live demonstrations of its assembly technology, including V-RAC. In Booth 5328 in the ...
The FDA recently issued draft guidances ... finding applications across medical devices and pharmaceutical development. In medical devices, AI models power tools such as software that analyzes ...
A new Supernus Pharmaceuticals medical device that continuously ... for the neurological disease wanes. The drug/device combination product, known in development as SPN-830, will be commercialized ...
The trade show floor offers a firsthand look at how market trends shape current design and manufacturing innovations.
The FDA’s Breakthrough Device Designation is reserved ... expediting the development and commercialization process for PathChat DX. The designation highlights the FDA’s recognition of the ...
Medical devices: AdvaMed CEO Scott Whitaker said tariffs function similarly to an excise tax — and that research and development spending ... for the generic drug industry, the group said ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market- Targeting Q1 2026 for expected clearance of the MODD1 in th ...
Repeated training is essential for ensuring that the workers are abreast of the latest technologies, ranging from software development ... in the medical device manufacturing process.
This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.
A breakthrough contraceptive device that potentially cures period pain, other pelvic pain and even headaches is seeking ...